Treatment of older patients with mantle-cell lymphoma
HC Kluin-Nelemans, E Hoster, O Hermine… - … England Journal of …, 2012 - Mass Medical Soc
… We randomly assigned patients 60 years of age or older with mantle-cell lymphoma, stage
II to IV, who were not eligible for high-dose therapy to six cycles of rituximab, fludarabine, and …
II to IV, who were not eligible for high-dose therapy to six cycles of rituximab, fludarabine, and …
Treatment of older patients with mantle cell lymphoma (MCL): long-term follow-up of the randomized European MCL elderly trial
HC Kluin-Nelemans, E Hoster, O Hermine… - Journal of Clinical …, 2020 - ascopubs.org
… In this mature update of the European MCL Network trial for older patients, we confirm the
initial results as far as PFS and OS are concerned after R-CHOP induction followed by long-…
initial results as far as PFS and OS are concerned after R-CHOP induction followed by long-…
Treatment of older patients with mantle cell lymphoma in the era of novel agents
A Rozental, HSL Jim, M Extermann - Leukemia & Lymphoma, 2023 - Taylor & Francis
… most promising results, this treatment is too toxic for older patients. Several lower-intensity …
in older patients with reduced toxicity profiles. However, older relapsed/refractory patients …
in older patients with reduced toxicity profiles. However, older relapsed/refractory patients …
Frontline treatment for older patients with mantle cell lymphoma
H Ye, A Desai, D Zeng, J Romaguera… - The Oncologist, 2018 - academic.oup.com
… the older patients with risk variables, frontline treatment is determined according to different
body status of fit, unfit or compromised, and frail. In the fit patients… compromised older patients…
body status of fit, unfit or compromised, and frail. In the fit patients… compromised older patients…
Treatment of elderly patients with mantle cell lymphoma
HC Kluin-Nelemans, JK Doorduijn - Seminars in hematology, 2011 - Elsevier
… Treatment of elderly patients with a mantle cell lymphoma (MCL) is a challenge. High-dose …
of the treatment in younger patients, are not feasible for most elderly patients. However, in fit …
of the treatment in younger patients, are not feasible for most elderly patients. However, in fit …
Treatment of the elderly patient with mantle cell lymphoma
P Soubeyran, R Gressin - Hematology 2014, the American …, 2016 - ashpublications.org
… Treatment options for mantle cell lymphomas have expanded considerably over recent …
solutions for older patients with an appropriate risk-to-benefit ratio. Indeed, unfit older patients are …
solutions for older patients with an appropriate risk-to-benefit ratio. Indeed, unfit older patients are …
Management of older adults with mantle cell lymphoma
JT Romancik, JB Cohen - Drugs & Aging, 2020 - Springer
… often have medical comorbidities that preclude such intensive therapy. Fortunately, an …
patient population. In this article, we will review the current treatment landscape for older adults …
patient population. In this article, we will review the current treatment landscape for older adults …
[HTML][HTML] Approach to the initial treatment of older patients with mantle cell lymphoma
J Ruan - Hematology/Oncology Clinics, 2020 - hemonc.theclinics.com
Mantle cell lymphoma (MCL) is a distinct subtype of non-Hodgkin lymphoma characterized by
t (11; 14)(… 1 With a median age of 65 years, MCL affects predominantly older patients with …
t (11; 14)(… 1 With a median age of 65 years, MCL affects predominantly older patients with …
[HTML][HTML] How to treat older patients with mantle cell lymphoma in the era of targeted drugs
T Robak, P Robak - Annals of Palliative Medicine, 2022 - apm.amegroups.org
… About 6% of all B-cell non-Hodgkin lymphoma (NHL) patients demonstrate the subtype
mantle cell lymphoma (MCL) (1), with most of these being older people: the median age at …
mantle cell lymphoma (MCL) (1), with most of these being older people: the median age at …
Management of mantle cell lymphoma in the elderly patient
JK Doorduijn, HC Kluin-Nelemans - Clinical interventions in aging, 2013 - Taylor & Francis
… of patients with mantle cell lymphoma is expected. Participation in well-designed clinical trials,
also by elderly patients… information on the tolerability of these treatments in this age group. …
also by elderly patients… information on the tolerability of these treatments in this age group. …